The most sensible answer is: if you have known diabetic retinopathy, recent visual symptoms, or no recent retinal exam, then yesan updated eye evaluation is wise
No effect was seen in the high-dose group (striped bars)
the FDA has approved Ozempic to manage type 2 diabetes and Wegovy for weight management in specific individuals
Notably, non-peptide small-molecule agonists of the GLP-1R are also being developed for oral bioavailability ( in silico evaluation of an -helical peptide (SR18: 18 aa) as a potent agonist of GLP-1R, with native GLP-1 and Semaglutide serving as references
less on alcohol, soft drinks, candy, and snacks
Instead of universal withholding, the guidance emphasized shared decision-making and targeted risk reduction for patients most likely to have delayed gastric emptying, such as those in the dose-escalation phase, those with notable gastrointestinal symptoms, those on higher doses, and those with comorbid conditions that slow gastric emptying